These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 18040766)
1. Inhibition of HPV-16 L1 expression from L1 cDNAs correlates with the presence of hnRNP A1 binding sites in the L1 coding region. Zhao X; Schwartz S Virus Genes; 2008 Feb; 36(1):45-53. PubMed ID: 18040766 [TBL] [Abstract][Full Text] [Related]
2. Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers. Zhao X; Fay J; Lambkin H; Schwartz S Virology; 2007 Dec; 369(2):351-63. PubMed ID: 17869320 [TBL] [Abstract][Full Text] [Related]
3. Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene. Zhao X; Rush M; Schwartz S J Virol; 2004 Oct; 78(20):10888-905. PubMed ID: 15452209 [TBL] [Abstract][Full Text] [Related]
4. Suppression of HPV-16 late L1 5'-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs. Li X; Johansson C; Glahder J; Mossberg AK; Schwartz S Nucleic Acids Res; 2013 Dec; 41(22):10488-508. PubMed ID: 24013563 [TBL] [Abstract][Full Text] [Related]
5. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region. Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322 [TBL] [Abstract][Full Text] [Related]
6. Specific interaction between hnRNP H and HPV16 L1 proteins: implications for late gene auto-regulation enabling rapid viral capsid protein production. Zheng ZZ; Sun YY; Zhao M; Huang H; Zhang J; Xia NS; Miao J; Zhao Q Biochem Biophys Res Commun; 2013 Jan; 430(3):1047-53. PubMed ID: 23261416 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing. Dhanjal S; Kajitani N; Glahder J; Mossberg AK; Johansson C; Schwartz S J Biol Chem; 2015 May; 290(21):13354-71. PubMed ID: 25878250 [TBL] [Abstract][Full Text] [Related]
8. Serine/Arginine-Rich Splicing Factor 3 and Heterogeneous Nuclear Ribonucleoprotein A1 Regulate Alternative RNA Splicing and Gene Expression of Human Papillomavirus 18 through Two Functionally Distinguishable cis Elements. Ajiro M; Tang S; Doorbar J; Zheng ZM J Virol; 2016 Oct; 90(20):9138-52. PubMed ID: 27489271 [TBL] [Abstract][Full Text] [Related]
9. Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 5' splice site, SD3632. Somberg M; Zhao X; Fröhlich M; Evander M; Schwartz S J Virol; 2008 Apr; 82(7):3665-78. PubMed ID: 18216120 [TBL] [Abstract][Full Text] [Related]
10. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure. Damgaard CK; Tange TO; Kjems J RNA; 2002 Nov; 8(11):1401-15. PubMed ID: 12458794 [TBL] [Abstract][Full Text] [Related]
11. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1. Najera I; Krieg M; Karn J J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777 [TBL] [Abstract][Full Text] [Related]
12. Polypyrimidine tract-binding protein and heterogeneous nuclear ribonucleoprotein A1 bind to human T-cell leukemia virus type 2 RNA regulatory elements. Black AC; Luo J; Watanabe C; Chun S; Bakker A; Fraser JK; Morgan JP; Rosenblatt JD J Virol; 1995 Nov; 69(11):6852-8. PubMed ID: 7474099 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of a novel reporter assay for human papillomavirus type 16 late gene expression. Orrù B; Cunniffe C; Ryan F; Schwartz S J Virol Methods; 2012 Aug; 183(2):106-16. PubMed ID: 22484615 [TBL] [Abstract][Full Text] [Related]
14. A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding. Marchand V; Méreau A; Jacquenet S; Thomas D; Mougin A; Gattoni R; Stévenin J; Branlant C J Mol Biol; 2002 Nov; 323(4):629-52. PubMed ID: 12419255 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry. Hindmarsh PL; Laimins LA Virol J; 2007 Feb; 4():19. PubMed ID: 17324266 [TBL] [Abstract][Full Text] [Related]
16. hnRNP L controls HPV16 RNA polyadenylation and splicing in an Akt kinase-dependent manner. Kajitani N; Glahder J; Wu C; Yu H; Nilsson K; Schwartz S Nucleic Acids Res; 2017 Sep; 45(16):9654-9678. PubMed ID: 28934469 [TBL] [Abstract][Full Text] [Related]
17. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B. Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309 [TBL] [Abstract][Full Text] [Related]
18. A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H. Oberg D; Fay J; Lambkin H; Schwartz S J Virol; 2005 Jul; 79(14):9254-69. PubMed ID: 15994820 [TBL] [Abstract][Full Text] [Related]
19. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Mayeda A; Krainer AR Cell; 1992 Jan; 68(2):365-75. PubMed ID: 1531115 [TBL] [Abstract][Full Text] [Related]
20. The human papillomavirus type 16 L1 protein directly interacts with E2 and enhances E2-dependent replication and transcription activation. Siddiqa A; Léon KC; James CD; Bhatti MF; Roberts S; Parish JL J Gen Virol; 2015 Aug; 96(8):2274-2285. PubMed ID: 25911730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]